News
Second Quarter 2025 Results Key Financial Results Revenue: US$3.68b (up ...
If you're looking to put cash into two fantastic biotech stocks that Wall Street seems particularly bullish on, there's one ...
Regeneron topped Wall Street estimates for second-quarter results on Friday, on robust demand for its blockbuster eczema drug ...
Two presentations discussed the significant care disruptions when there are copay assistance shortages, with patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results